This was the stock's second consecutive day of losses.

Cigna’s latest SWOT analysis shows a company flexing its market muscles despite tricky healthcare headwinds. Cigna’s strong ...

Guggenheim has reaffirmed its buy rating on The Cigna Group, setting a target price of $388, making investors grin. The Cigna ...

On Friday, May 23, UBS analyst AJ Rice reaffirmed a “Buy” rating on The Cigna Group (NYSE: CI) with a price target of $390.

You probably wouldn’t bet on a horse that usually finishes in the middle of the pack. But, in the stock market, sometimes ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Cigna Healthcare® has sponsored and provided editorial input on this article. Community-focused well-being initiatives are a critical component of the value that hospitals and health systems provide ...

Hims & Hers has delivered strong results and partnerships, but recent Cigna/Novo Nordisk news increases competitive risk and ...

The new weight-loss option will cut what the plan sponsors pay as well as what the patients pay, Cigna’s PBM Evernorth says.

The price is a lot steeper than the average of $450,000 to $500,000 a year insurer XL Group paid, starting in December 2007.

The Cigna Group (NYSE: CI )’s Evernorth division has announced a new deal with Novo Nordisk and Eli Lilly that will limit ...

Cigna has announced a deal to cap client copays on popular GLP-1 weight loss drugs by Eli Lilly and Novo Nordisk at $200 per ...